The Ohio State University
- Advisory Board: AstraZeneca; Eli Lilly and Company, Novartis Pharmaceutical Corporation, Noven Pharmaceuticals, Neuropharm Group plc, Shire Pharmaceuticals Inc., Seaside; Novartis Pharmaceutical Corporation; Noven Pharmaceuticals; Seaside Therapeutics; Shire Pharmaceuticals Inc.
- Consultant: Eli Lilly and Company, Novartis Pharmaceutical Corporation, Noven Pharmaceuticals, Neuropharm Group plc, Shire Pharmaceuticals Inc., Seaside; Neuropharm Group plc; Noven Pharmaceuticals; Organon International Inc.; Shire Pharmaceuticals Inc.; Targacept; Targacept, Inc.
- Honorarium for participation in this meeting: American Academy of Child and Adolescent Psychiatry
- Research Support: Autism Speaks Inc.; CureMark; Curemark, LLC; Eli Lilly and Company; Eli Lilly and Company, Novartis Pharmaceutical Corporation, Noven Pharmaceuticals, Neuropharm Group plc, Shire Pharmaceuticals Inc., Seaside; Neuropharm Group plc; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.; Targacept